Shattuck Labs (STTK) Amortizatization of Intangibles (2021 - 2026)
Shattuck Labs (STTK) posted quarterly Amortizatization of Intangibles of $48000.0 for Q1 2026, up 2300.0% year-over-year from $2000.0 in Q1 2025, and down 83.22% quarter-over-quarter from $286000.0 in Q4 2025.
Powered by 
Analysis
Shattuck Labs (STTK) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Amortizatization of Intangibles for 6 consecutive years, with $48000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 2300.0% year-over-year to $48000.0; the TTM figure through Mar 2026 stood at $499000.0 (down 72.0% YoY), while the FY2025 annual figure was $453000.0, down 78.94% from the prior year.
- Amortizatization of Intangibles slipped to $48000.0 in Q1 2026 per STTK's latest filing, from $286000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $742000.0 in Q3 2024 and bottomed at -$981000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $162647.1 across 5 years, with a median of $213000.0 in 2023.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles plunged 20650.0% — and 2026, when it surged 2300.0%.
- Shattuck Labs' Amortizatization of Intangibles stood at $139000.0 in 2022, then jumped by 207.91% to $428000.0 in 2023, then dropped by 1.64% to $421000.0 in 2024, then tumbled by 32.07% to $286000.0 in 2025, then tumbled by 83.22% to $48000.0 in 2026.
- Business Quant data shows STTK's Amortizatization of Intangibles at $48000.0 in Q1 2026, $286000.0 in Q4 2025, and $166000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - | 111,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111,000.00 |
| Mar 31, 2026 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 373,000.00 |
| Jun 30, 2025 | -117,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Sep 30, 2024 | 742,000.00 |
| Jun 30, 2024 | 617,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Dec 31, 2023 | 428,000.00 |
| Sep 30, 2023 | 551,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Mar 31, 2023 | 213,000.00 |
| Dec 31, 2022 | 139,000.00 |
| Sep 30, 2022 | -113,000.00 |
| Jun 30, 2022 | -415,000.00 |
| Mar 31, 2022 | -981,000.00 |
| Dec 31, 2021 | -2.26 Mn |
| Sep 30, 2021 | -772,000.00 |